• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature.

作者信息

María Pablo Santa, Valenzuela Fernando, Morales Claudia, la Fuente Raul De, Cullen Roberto

机构信息

Dermatology Department, University of Chile Clinical Hospital.

Department of Pathology, Dermopathology Section, University of Chile Clinical Hospital.

出版信息

Dermatol Reports. 2017 Oct 11;9(2):7079. doi: 10.4081/dr.2017.7079.

DOI:10.4081/dr.2017.7079
PMID:29090075
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5646428/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce42/5646428/14adeccdb844/dr-9-2-7079-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce42/5646428/bec77347d53f/dr-9-2-7079-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce42/5646428/822e32b52dea/dr-9-2-7079-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce42/5646428/14adeccdb844/dr-9-2-7079-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce42/5646428/bec77347d53f/dr-9-2-7079-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce42/5646428/822e32b52dea/dr-9-2-7079-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce42/5646428/14adeccdb844/dr-9-2-7079-g003.jpg

相似文献

1
Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature.在用司库奇尤单抗治疗期间银屑病斑块消退过程中出现的雀斑样疹：一例病例报告及文献复习
Dermatol Reports. 2017 Oct 11;9(2):7079. doi: 10.4081/dr.2017.7079.
2
Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.依奇珠单抗治疗中重度斑块状银屑病：NICE 单技术评估的循证评估组观点。
Pharmacoeconomics. 2018 Aug;36(8):917-927. doi: 10.1007/s40273-018-0629-2.
3
Ixekizumab: A Review of Its Use for the Management of Moderate to Severe Plaque Psoriasis.依奇珠单抗：用于治疗中度至重度斑块型银屑病的研究进展。
Ann Pharmacother. 2019 Mar;53(3):276-284. doi: 10.1177/1060028018799982. Epub 2018 Sep 6.
4
Crohn's-like disease in a patient exposed to anti-Interleukin-17 blockade (Ixekizumab) for the treatment of chronic plaque psoriasis: a case report.抗白细胞介素-17 阻断剂（依奇珠单抗）治疗慢性斑块状银屑病致克罗恩样疾病 1 例报告。
BMC Gastroenterol. 2019 Sep 5;19(1):162. doi: 10.1186/s12876-019-1067-0.
5
Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52-week, open-label, phase 3 study (UNCOVER-J).司库奇尤单抗治疗日本中重度斑块状银屑病、红皮病型银屑病和泛发性脓疱型银屑病患者的疗效和安全性：一项为期52周的开放标签3期研究（UNCOVER-J）的结果
J Dermatol. 2017 Apr;44(4):355-362. doi: 10.1111/1346-8138.13622. Epub 2016 Oct 11.
6
Ixekizumab for treatment of adults with moderate-to-severe plaque psoriasis and psoriatic arthritis.司库奇尤单抗用于治疗中度至重度斑块状银屑病和银屑病关节炎的成人患者。
Expert Rev Clin Pharmacol. 2016 Nov;9(11):1423-1433. doi: 10.1080/17512433.2016.1242409. Epub 2016 Oct 11.
7
Ixekizumab for the Treatment of Psoriasis: A Review of Phase III Trials.依奇珠单抗治疗银屑病：III 期临床试验综述。
Dermatol Ther (Heidelb). 2016 Mar;6(1):25-37. doi: 10.1007/s13555-016-0102-0. Epub 2016 Feb 24.
8
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.依奇珠单抗治疗中重度斑块状银屑病的 3 期临床试验。
N Engl J Med. 2016 Jul 28;375(4):345-56. doi: 10.1056/NEJMoa1512711. Epub 2016 Jun 8.
9
Ixekizumab for the treatment of psoriasis: an update on new data since first approval.依奇珠单抗治疗银屑病：首次批准以来新数据的更新。
Expert Rev Clin Immunol. 2019 Feb;15(2):111-121. doi: 10.1080/1744666X.2019.1559730. Epub 2018 Dec 27.
10
Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3).在依那西普无反应者中转换为司库奇尤单抗的疗效和安全性：来自两项中重度斑块状银屑病III期随机临床试验（UNCOVER-2和-3）的亚组分析
Am J Clin Dermatol. 2017 Apr;18(2):273-280. doi: 10.1007/s40257-016-0246-9.

引用本文的文献

1
Cutaneous Changes Beyond Psoriasis: The Impact of Biologic Therapies on Angiomas and Solar Lentigines.银屑病之外的皮肤变化：生物疗法对血管瘤和日光性雀斑的影响
Medicina (Kaunas). 2025 Mar 22;61(4):565. doi: 10.3390/medicina61040565.
2
Recurrence of psoriasis on the resolution sites left with lentiginous pigmented patches after TNF inhibitor therapy.肿瘤坏死因子抑制剂治疗后，在遗留有雀斑样色素沉着斑的消退部位出现银屑病复发。
An Bras Dermatol. 2023 Nov-Dec;98(6):866-867. doi: 10.1016/j.abd.2022.04.015. Epub 2023 Jun 23.
3
Case Reports of DRESS Syndrome and Symptoms Consistent with DRESS Syndrome Following Treatment with Recently Marketed Monoclonal Antibodies.

本文引用的文献

1
Melanocyte antigen triggers autoimmunity in human psoriasis.黑素细胞抗原引发人类银屑病中的自身免疫。
J Exp Med. 2015 Dec 14;212(13):2203-12. doi: 10.1084/jem.20151093. Epub 2015 Nov 30.
2
Multiple lentigines confined to psoriatic plaques induced by biologic agents in psoriasis therapy: a case and review of the literature.银屑病治疗中生物制剂诱发的局限于银屑病斑块的多发性雀斑样痣：1例病例及文献复习
Cutan Ocul Toxicol. 2015;34(3):262-4. doi: 10.3109/15569527.2014.959664. Epub 2015 Mar 25.
3
Multiple lentigines in areas of resolving psoriatic plaques after ustekinumab therapy.
药物超敏反应伴嗜酸性粒细胞增多和系统症状（DRESS）综合征病例报告以及使用近期上市的单克隆抗体治疗后出现的符合DRESS综合征的症状
Autoimmune Dis. 2019 Jun 9;2019:7595706. doi: 10.1155/2019/7595706. eCollection 2019.
使用乌司奴单抗治疗后，银屑病斑块消退区域出现多发性雀斑样痣。
Dermatol Online J. 2014 Apr 16;20(4):22338.
4
IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis.白细胞介素-17 和肿瘤坏死因子协同调节细胞因子表达，同时抑制黑色素生成：与银屑病的潜在相关性。
J Invest Dermatol. 2013 Dec;133(12):2741-2752. doi: 10.1038/jid.2013.237. Epub 2013 Apr 30.
5
Mechanisms underlying post-inflammatory hyperpigmentation: lessons from solar lentigo.炎症后色素沉着的潜在机制：来自日光性雀斑的启示。
Ann Dermatol Venereol. 2012 Dec;139 Suppl 4:S148-52. doi: 10.1016/S0151-9638(12)70127-8.
6
The role of keratinocyte growth factor in melanogenesis: a possible mechanism for the initiation of solar lentigines.角质形成细胞生长因子在黑色素生成中的作用：太阳黑子形成的可能机制。
Exp Dermatol. 2010 Oct;19(10):865-72. doi: 10.1111/j.1600-0625.2009.00957.x.
7
Multiple lentigines arising in resolving psoriatic plaques after treatment with etanercept.使用依那西普治疗后，在消退的银屑病斑块中出现多发性雀斑样痣。
Dermatol Online J. 2008 Jan 15;14(1):11.
8
Multiple lentigines confined to resolving psoriatic plaques in a patient treated with adalimumab.在用阿达木单抗治疗的患者中，多发性雀斑样痣局限于正在消退的银屑病斑块。
Dermatology. 2008;216(3):279. doi: 10.1159/000113947. Epub 2008 Jan 24.
9
Multiple lentigines confined to psoriatic plaques.局限于银屑病斑块内的多发性雀斑样痣。
Clin Exp Dermatol. 1994 Sep;19(5):380-2. doi: 10.1111/j.1365-2230.1994.tb02686.x.